420 related articles for article (PubMed ID: 932193)
21. Comparison between 1alpha(OH)D3 and 1,25(OH)2D3 on the suppression of plasma PTH levels in uremic patients, evaluated by the 'whole' and 'intact' PTH assays.
Brandi L; Egfjord M; Olgaard K
Nephron Clin Pract; 2005; 99(4):c128-37. PubMed ID: 15722644
[TBL] [Abstract][Full Text] [Related]
22. Jejunal and ileal absorption in patients with chronic renal disease. Effect of 1alpha-hydroxycholecalciferol.
Vergne-Marini P; Parker TF; Pak CY; Hull AR; DeLuca HF; Fordtran JS
J Clin Invest; 1976 Apr; 57(4):861-6. PubMed ID: 947957
[TBL] [Abstract][Full Text] [Related]
23. Effect of 25-hydroxyvitamin D3 on vitamin D metabolites in primary biliary cirrhosis.
Kaplan MM; Goldberg MJ; Matloff DS; Neer RM; Goodman DB
Gastroenterology; 1981 Oct; 81(4):681-5. PubMed ID: 6973499
[TBL] [Abstract][Full Text] [Related]
24. [Comparative study of the effect of 1,25 dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on calcium homeostasis and bone tissue state in rats during hypokinesia].
Sergeev IN; Blazheevich NV; Kaplanskiĭ AS; Shvets VN; Belakovskiĭ MS
Vopr Med Khim; 1987; 33(1):100-7. PubMed ID: 3495067
[TBL] [Abstract][Full Text] [Related]
25. Reversal of skeletal resistance to parathyroid hormone in uremia by vitamin D metabolites: evidence for the requirement of 1,25(OH)2D3 and 24,25(OH)2D3.
Massry SG; Tuma S; Dua S; Goldstein DA
J Lab Clin Med; 1979 Jul; 94(1):152-7. PubMed ID: 469372
[TBL] [Abstract][Full Text] [Related]
26. Unique effects of 24,25-dihydroxyvitamin D3 in uremic patients.
Llach F; Brickman AS; Coburn JW
Contrib Nephrol; 1980; 18():212-7. PubMed ID: 7353377
[TBL] [Abstract][Full Text] [Related]
27. The photoproduction of 1 alpha,25-dihydroxyvitamin D3 in skin: an approach to the therapy of vitamin-D-resistant syndromes.
Holick MF; Uskokovic M; Henley JW; MacLaughlin J; Holick SA; Potts JT
N Engl J Med; 1980 Aug; 303(7):349-54. PubMed ID: 6248779
[TBL] [Abstract][Full Text] [Related]
28. Role of 1,25-dihydroxyvitamin D3 on intestinal phosphate absorption in rats with a normal vitamin D supply.
Rizzoli R; Fleisch H; Bonjour JP
J Clin Invest; 1977 Sep; 60(3):639-47. PubMed ID: 893667
[TBL] [Abstract][Full Text] [Related]
29. Effects of vitamin D and its metabolites on calcium transport in the diabetic rat.
Schneider LE; Omdahl J; Schedl HP
Endocrinology; 1976 Sep; 99(3):793-9. PubMed ID: 182468
[TBL] [Abstract][Full Text] [Related]
30. Structure-function studies on analogues of 1 alpha,25-dihydroxyvitamin D3: differential effects on leukemic cell growth, differentiation, and intestinal calcium absorption.
Norman AW; Zhou JY; Henry HL; Uskokovic MR; Koeffler HP
Cancer Res; 1990 Nov; 50(21):6857-64. PubMed ID: 2208153
[TBL] [Abstract][Full Text] [Related]
31. Effects of 1alpha,25-dihydroxyvitamin D3 and Solanum glaucophyllum on intestinal calcium and phosphate transport and on plasma Ca, Mg and P levels in the rat.
Walling MW; Kimberg DV
Endocrinology; 1975 Dec; 97(6):1567-76. PubMed ID: 1204578
[TBL] [Abstract][Full Text] [Related]
32. Effect of 1alpha-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on intestine and bone in glucocorticoid-treated patients.
Lund B; Andersen RB; Friis T; Hjorth L; Jørgensen FS; Norman AW; Sørensen OH
Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():177s-181s. PubMed ID: 606415
[TBL] [Abstract][Full Text] [Related]
33. Effect of 1,25(OH)2D3 and 24,25(OH)2D3 on experimental rickets.
Kraft D; Offermann G; Steldinger R; Gawlik D
Res Commun Chem Pathol Pharmacol; 1979 Dec; 26(3):571-80. PubMed ID: 523788
[TBL] [Abstract][Full Text] [Related]
34. Action of 1,25-dihydroxyvitamin D3 and a diphosphonate on calcium metabolism in rats.
Bonjour JP; Trechsel U; Fleisch H; Schenk R; DeLuca HF; Baxter LA
Am J Physiol; 1975 Aug; 229(2):402-8. PubMed ID: 808969
[TBL] [Abstract][Full Text] [Related]
35. Long-term administration of vitamin D steroles in incipient and advanced renal failure: effect on bone histology.
Malluche HH; Ritz E; Werner E; Meyer-Sabellek WA
Clin Nephrol; 1978 Dec; 10(6):219-28. PubMed ID: 215365
[TBL] [Abstract][Full Text] [Related]
36. 1-alpha-hydroxyvitamin D3 in chronic renal failure. A potent analogue of the kidney hormone, 1,25-dihydroxycholecalciferol.
Chan JC; Oldham SB; Holick MF; DeLuca HF
JAMA; 1975 Oct; 234(1):47-52. PubMed ID: 1174223
[TBL] [Abstract][Full Text] [Related]
37. Effects of 1 alpha-hydroxylated metabolites of cholecalciferol on intestinal radiocalcium absorption in goats.
Hove K
Br J Nutr; 1984 Jan; 51(1):157-64. PubMed ID: 6546296
[TBL] [Abstract][Full Text] [Related]
38. [Comparative study of the toxicity of 1 alpha-hydroxyvitamin D3 and 24,25 (RS)-dihydroxyvitamin D3 in rats].
Khaĭdakov MS; Alekseeva IA; Belakovskiĭ MS; Blazheevich NV; Spirichev VB
Farmakol Toksikol; 1985; 48(4):106-9. PubMed ID: 3876239
[TBL] [Abstract][Full Text] [Related]
39. Is 24,25-dihydroxycholecalciferol a calcium-regulating hormone in man?
Kanis JA; Cundy T; Bartlett M; Smith R; Heynen G; Warner GT; Russell RG
Br Med J; 1978 May; 1(6124):1382-6. PubMed ID: 647302
[TBL] [Abstract][Full Text] [Related]
40. The ionic control of 1,25-dihydroxyvitamin D3 synthesis in isolated chick renal mitochondria. The role of calcium as influenced by inorganic phosphate and hydrogen-ion.
Bikle DD; Murphy EW; Rasmussen H
J Clin Invest; 1975 Feb; 55(2):299-304. PubMed ID: 236327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
